Randomized trial of ofatumumab and bendamustine versus ofatumumab, bendamustine, and bortezomib in previously untreated patients with high-risk follicular lymphoma: CALGB 50904 (Alliance)
Kristie A. Blum, Mei Yin Polley, Sin Ho Jung, Travis J. Dockter, Sarah Anderson, Eric D. Hsi, Nina Wagner-Johnston, Beth Christian, Jim Atkins, Bruce D. Cheson, John P. Leonard, Nancy L. Bartlett
Dive into the research topics of 'Randomized trial of ofatumumab and bendamustine versus ofatumumab, bendamustine, and bortezomib in previously untreated patients with high-risk follicular lymphoma: CALGB 50904 (Alliance)'. Together they form a unique fingerprint.